Skip to content

EBITDA margin at other companies

Schrodinger logo
SchrodingerSDGR
-62.3%-11.6pp
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-754.8%-93.5pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-17,462.5%-18,885pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-237.8%-104pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
17.8%+9.7pp
ADMA Biologics logo
ADMA BiologicsADMA
43.7%+8.9pp

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on trailing twelve months.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's EBITDA margin?
Absci Corporation (ABSI) reported EBITDA margin of -6,102.2% in Q1 2026.
How has Absci Corporation's EBITDA margin changed year-over-year?
Absci Corporation's EBITDA margin decreased by 193.6% year-over-year, from -2,078.4% to -6,102.2%.
What is the long-term trend for Absci Corporation's EBITDA margin?
Over 5 years (2020 to 2025), Absci Corporation's EBITDA margin has grown at a 72.4% compound annual growth rate (CAGR), from -254.6% to -3,877.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.